Current pharmacotherapy options of drug-induced liver injury (DILI) remain under
discussion and are now evaluated in this analysis. Needless to say, the use of the offending …

Drug induced liver injury (DILI) occurs in patients exposed to drugs at recommended doses
that leads to idiosyncratic DILI and provides an excellent human model with well described …

Drug-induced fatty liver disease (DIFLD) is a basic clinicopathological example of drug-
induced liver injury (DILI). Some drugs can inhibit β-oxidation in hepatocyte mitochondria …

Objective Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming a significant global
health concern, representing the leading cause of chronic liver disease and posing a …

Liver fibrosis is an excessive production, aberrant deposition, and deficit degradation of
extracellular matrix (ECM). Patients with unresolved fibrosis ultimately undergo end-stage …

Elevated liver enzyme levels are a frequent incidental finding in primary care, and non-
alcoholic fatty liver disease is the main cause of incidental elevation of liver enzymes …

Psoralea corylifolia L.(P. corylifolia) has attracted increasing attention because of its
potential hepatotoxicity. In this study, we used network analysis (toxic component and …

In the current investigation, Annona muricata Linn. lyophilized fruit pulp powder was
evaluated for its hepatoprotective activity induced by paracetamol or acetaminophen …

In response to the COVID-19 pandemic, the Korean government implemented policies
including the systematic social distancing (SSD) system which started on 28 June 2020. The …

Drug induced fatty liver disease (DIFLD) is a form of drug-induced liver injury (DILI), which
can also be included in the more general metabolic dysfunction-associated steatotic liver …